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Introduction
Over the past two decades, there has been an increasing interest in imaging the prostate gland in men whose clinical presentation includes rising PSA levels suspicious for prostate cancer (PCa). To date, MRI has been the most promising non-invasive imaging technique for detection and characterization of malignant lesions [1, 2] and identification of patients with high-risk PCa [3] [4] [5] [6] [7] . In addition, multiparametric (mp) MRI, which combines anatomical imaging with diffusion-weighted and dynamic contrastenhanced imaging [8] , has reported the highest detection rate of significant PCa (volume > 0.5 cm 3 ). Recently, MRI at a field strength of 3 Tesla has been increasingly performed [9] to improve cancer detection, but mpMRI at 3 Tesla is still not being used as a stand-alone test for PCa because it fails to identify 13% of men with high grade lesions of Gleason score ≥7 [10] . Despite advances in MRI techniques, current MRI-based imaging in clinical practice does not provide optimum resolution for accurate correlation and estimation of PCa contours, volume and grade. Lack of optimum resolution, by turn, limits the ability to make informed clinical decisions, such as eligibility for active surveillance, focal therapy or nerve-sparing. It is evident that, while MRI is capable of detecting a gross abnormality associated with invasive PCa, the current spatial resolution is inadequate to characterize lesions at a microscopic level that may be crucial for early detection of PCa and determination of accurate extent and aggressiveness.
The present work was performed to address the abovementioned limitations of current prostate MRI, with specific attention to spatial resolution. Two magnetic field strengths and a range of spatial resolution, including those currently beyond the capabilities available in the clinic, were tested on ex vivo prostate specimens using a home-built experimental MRI set-up. We hypothesized that 7-Tesla MRI could facilitate the spatial resolution necessary for identification of prostatic tissue at microscopic resolution, that would in turn enable accurate localization and risk characterization of PCa. The ultimate goal of the present study was to explore ex vivo 3-Tesla and 7-Tesla MRI best acquisition parameters that may serve as a guide for future in vivo imaging, in particular, regarding the anatomical length scales that are relevant for PCa diagnosis.
Material and Methods

Study Cohort
Human prostate glands (n = 15) were obtained from both organ donors (n = 3) and subjects who underwent robotassisted radical prostatectomy (RARP; n = 12) as part of their clinical care at our institute. Imaging of RARP specimens was carried out with approval of our institutional review board, while specimens from organ donors were collected from subjects whose relatives had previously signed permission.
Specimen Preparation and Handling
Imaging ex vivo whole glands Fresh excised whole prostatectomy glands from organ donors (n = 3) or subjects who underwent RARP (n = 6), were covered with a saline-soaked gauze and sealed in a plastic bag. The glands were delivered to our imaging centre within 30 min of removal from the body.
Imaging ex vivo tissue sections
The RARP specimens (n = 6) were first submitted to surgical pathology for gross examination. After inking the specimen according to a standard protocol, the fresh prostate gland, i.e. before formalin fixation, was sectioned from apex to base into 5-mm thick slices. These slices were inspected visually for the presence of tumour. The gross localization of the tumour in these sections was aided by preoperative positive prostate biopsy cores and preoperative MRI reports. The fresh tissue section with the highest probability of tumour was selected for imaging. Depending on the size of the section, the section was divided in half or quartered to fit inside a standard pathology cassette, measuring~30 9 27 9 5 mm 3 . This cassette was then immersed in a solution containing a mixture of 0.9% saline and 1% Gd-DTPA, and was delivered to the imaging centre. For whole prostate glands and sections from the RARP procedure, all imaging was performed within 3 h of excision. This was in accordance with the imaging time approved by the institutional review board. For specimens obtained from organ donors, no time limit was set for imaging.
MRI at 3 Tesla
Whole gland images were acquired using a General Electric SIGNA EXCITE MRI system. This system was chosen since it is also used for in vivo imaging, and afforded the same choice of imaging parameters for excised samples. A parallel wound solenoidal transmit/receive resonator was used for transmission and reception (Fig. 1A) . Details of the resonator design have been described previously [6] . Following a fast gradient echo technique for precise localization of the specimen within the scanner, a spin echo sequence was applied using pulse parameters that were designed to produce image contrast nearly identical to that obtained for clinical imaging of the prostate (protocols A and B). Maximum intensity projections were applied to slices acquired from the whole gland.
MRI at 7 Tesla
Images were acquired on a Bruker Biospec 30 cm bore MRI system equipped with B-GA 12S gradient coils rated at 450 mT/m (Fig. 1B) . For whole gland imaging, the radiofrequency resonator was similar to that constructed for 3 Tesla. For imaging of sections, an apparatus was constructed consisting of a platform of pine wood isolated from the magnet bore by polyethylene foam cylinders at either end (Fig. 1C) . On the platform a clear acrylic container was mounted upright. A three-turn parallel wound solenoidal resonator design was fixed to the container via adhesive backing on the copper foil comprising the loops. The container was designed to accept the plastic pathology cassette which had outer dimensions of 41 9 29 9 7 mm shot (FLASH) gradient echo acquisitions. The first (protocol E) was a two-dimensional acquisition and was used solely for rapidly assessing the permeability of the gland section to the contrast agent with a scan time of 7 min 47 s and a spatial resolution of 107 9 107 9 500 lm 3 . The second threedimensional FLASH gradient echo sequence (protocol F) was used for the highest resolution overnight specimen imaging of duration 8 h 36 min at 60 9 60 9 60 lm 3 . The third threedimensional FLASH acquisition (protocol G) was selected for imaging RARP specimens before histological evaluation for clinical care with identical parameters to protocol F, with the exception of the matrix size of 1024 9 1024 9 128 at a spatial resolution of 60 9 60 9 90 lm 3 . Protocol G had number of excitations = 3 and acquisition took 2 h and 51 min. The second and third FLASH sequences allowed full coverage of the 5-mm thick specimen which aided subsequent registration with histology. All protocol parameters are shown in Table 1 .
Histopathology and Correlation Study
After completion of imaging, RARP specimens (both whole glands and sections) were submitted in 10% buffered formalin to surgical pathology for routine histopathological evaluation. The tumour was manually outlined and Gleason graded on an haematoxylin and eosin (H&E)-stained slide by a pathologist. Post-processed digital images were generated from the delimited PCa area, annotated on the glass slides using a flatbed scanner. MRI results were compared with histopathology via visual inspection. The whole gland was also submitted for final pathology diagnosis but no attempt was made to correlate the MRI signature with histology.
Results
Imaging protocol A at 3 Tesla required a scan time of 14 min to cover the entire gland in 85 slices, and yielded a spatial the apparatus include polyethylene foam supports for precise positioning of the sample at the magnet isocenter, a pine wood platform for the resonator and cassette assembly (with cover removed), a variable capacitor on each of the three resonator loops, an inductively coupled matching loop with variable capacitor for impedance matching to the 50-ohm transmission line, a reservoir for the saline and Gd-DTPA mixture in which the cassette and sample were immersed, and finally, a cassette which is identical to that used for specimen preparation in pathology.
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© 2016 The Authors BJU International © 2016 BJU International resolution of 188 9 312 9 1000 lm 3 as presented in Fig. 2B , featuring a section of the gland obtained after RARP. This is compared with the preoperative imaging at 1.5 Tesla (Fig. 2A , at a clinical resolution of 547 9 625 9 3000 lm 3 ). A large hypointense zone was identified on the 3-Tesla MRI in the lower left peripheral zone (Fig. 2B) . This area corresponded to PCa with a Gleason score of 7 (4 + 3) on histology (Fig. 2C) . In addition to this large hypointense area, some scattered smaller foci of hypointensity were identified that did not correspond to any tumours on final H&E stains (Fig. 2C) .
At higher spatial resolution the conventional criterion for diagnosis of malignancy on T 2 -weighted images becomes untenable. In Fig. 2D a section of whole gland imaged at 7 Tesla is presented using relaxation enhancement acquisition parameters (protocol C). This image of a different specimen is shown at a spatial resolution of 100 9 107 9 750 lm 3 , obtained with a scan time of 11 min. Much greater detail is evident, as areas of stroma surrounding the ductal architecture begin to be elucidated. Individual ducts are well defined in some cases, and overall, the fundamental relevant length scale of the prostate gland begins to be approached, as defined by visualization of the important microscopic morphological structures that comprise the gland. However, as with carcinoma, the stroma is also defined by multiple areas of signal hypointensity.
The overall depiction of the gland was complemented by a maximum intensity projection presentation as, for example, obtained in 8 min 30 s at 3 Tesla (protocol B; Fig. 3 ). In this case the projection allows good visualization of multiple variegated smooth rounded nodules in the central zone indicative of BPH. In the peripheral zone, the magnification highlights superposition of different concentric layers corresponding to the histology of prostatic stromal layers which constitutes the glandular surface.
Another 7-Tesla spin echo image from a whole gland specimen is shown in Fig. 4 . This highlights vasculature and resolution of the urethral wall using a surface coil to image a small area. Using imaging protocol C, the visible structures clearly approach the microscopic scale, as shown in the magnification within the white dashed line. Microanatomy of intraprostatic tissue is well defined on MRI.
A specimen from a patient with PCa is shown in Fig. 5 at the highest spatial resolution acquired at 7 Tesla. An attempt was made to minimize the acquisition time while still retaining essential features of the gland on a three-dimensional gradient echo image. The image was obtained at a resolution of 60 9 60 9 90 lm 3 in 3 h (protocol G). At this resolution it is possible to observe specific aggregations of cells (outlined) showing tumour and reported as low signal and confirmed to be a high-grade PCa in the corresponding H&E-stained slide. A maximum intensity projection through the same stack provides a ductogram (Fig. 5B ) that highlights the lack of normal ductal structure in the region of PCa.
In Fig. 6 , fresh sections containing prostatic adenocarcinoma from three RARP specimens were also obtained at 7 Tesla with a resolution of 60 9 60 9 90 lm 3 (protocol G). Specimens were subsequently submitted for routine histopathological evaluation and found to have Gleason scores 4 + 3 = 7 (Fig. 6C) , 4 + 4 = 8 (Fig. 6F ) and 4 + 5 = 9 (Fig. 6I) . In all three sections imaged, 7-Tesla MRI accurately delineated the microarchitecture of prostatic tissue, including ducts, glands, blood vessels and stroma. Benign glands had hyperintense luminal secretions and relatively smooth, round borders, in contrast to tumour areas which had hypointense signals and often ill-defined ducts. The images were similar to low-magnification (92) histopathology. Furthermore, the ductograms augmented the distinction between benign and malignant tissue by highlighting the absence of normal ducts with their bright (hyperintense signal) luminal secretions in the areas of invasive carcinoma. The comparative comparative features of prostatic tissue using each protocol at both 3 Tesla and 7 Tesla are shown in Table 2 .
Discussion
The aim of the present study was to investigate imaging parameters using high-resolution MRI that may ultimately enable in vivo diagnosis at a microscopic level. Two distinct MRI regimes were pursued. The first was to image ex vivo whole glands at 3 Tesla and 7 Tesla with clinically available equipment but at a much higher spatial resolution, not practical in current clinical settings. The second was to image ex vivo prostate sections with an experimental 7-Tesla MRI set-up for generating optimum contrast in desired structures within a scan time acceptable for a subsequent pathological examination.
There is a well-known large array of methods for parametric imaging that has already been applied to the prostate, and several studies specifically address comparisons with radical prostatectomy histology [5] to better understand how imaging parameters relate to the histological features involved. A prospective correlation study comparing 1.5 Tesla and 3 Tesla MRI findings with final RARP pathology showed that cancer detection on mpMRI was influenced by multiple factors including tumour characteristics, such as Gleason score, volume, location and architecture (P < 0.001), but not by field strength or coils [11] . To date, much of the concern is only focused on gross pathological findings as much as tumour volume, gross architecture and Gleason score assessed by contrast signal intensity on clinical MRI. Based on the present results, we assume that, as spatial resolution improves, especially through the use of higher field strengths such as 7 Tesla or 9.4 Tesla [12] , it will be possible to separately characterize stroma, ducts, vasculature, concretions and carcinoma by virtue of T 1 or T 2 relaxation times, diffusion coefficients, as well as dynamic contrast enhancement and spectral characteristics. In this respect, we showed that 7-Tesla MRI can accurately delineate the microarchitecture of prostatic tissue. As non-invasive imaging techniques improve in the future, tissue identification may become possible. We found that benign glands had relatively smooth borders with hyperintense luminal secretion and hypointense concretions on FLASH images. By contrast, tumour areas had hypointense signal gradient echo images and could be delimited providing a tumour volume estimation. Interestingly in this regard, a discrepancy has been noted in the delineation of tumour boundary contours in MRI vs final pathology using a clinical 3-Tesla MRI unit [13] . In the present study, the higher resolution achievable at 7 Tesla allowed close correspondence to final histopathology.
Thus far in the clinical setting, diffusion-weighted imaging with an apparent diffusion coefficient map is the most helpful MRI method to predict cancer aggressiveness [14] . Notably, identification of clinically significant cancer that is defined by the presence of Gleason grade 4 or 5 is crucial for decisionmaking and could have been estimated in the present study by examination of microscopic features of the glandular architecture provided by 7-Tesla MRI. In practical terms, small-sized well-defined glands corresponding to Gleason grade 3 and bigger/fused ill-defined glands corresponding to Gleason grades 4 or 5 could be distinguished which were consistent with previously published preliminary data [15] . Ductograms enhanced the distinction between benign and malignant tissue and enabled a characterization of PCa aggressiveness by highlighting the absence of normal ductal structures (with their bright luminal secretions) in the areas of invasive carcinoma.
We have determined that the relevant length scale for proper characterization of PCa in the context of normal features of the prostate gland may be near a spatial resolution of 60 9 60 9 90 lm 3 . At this resolution, features are similar to (92) histopathology. The aim of the present study was to identify a radiological phenotype of PCa that may be useful in the future. While the relatively small number of specimens in this study limits our conclusions, it is reasonable to speculate that, given the rapid pace of advancement of radiological imaging techniques, in vivo clinical images will begin to approach the histological frontier in the not too distant future. It does appear evident from the present work that radiologists will evaluate forms of image contrast considerably different from those now accepted in order to properly interpret true high-resolution images of the prostate gland.
In conclusion, imaging of the human prostate gland has been presented that approaches histological spatial resolution, allowing the visualization of micro-anatomy of the gland. High-grade PCa was readily identified and characterized by radiological features similar to corresponding histology. Our results suggest that, while translation of the methods to the clinic are not imminent, high-resolution MRI affords an opportunity to achieve close correspondence with histology in the characterization of the most important features of benign and malignant anatomy.
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